The CDC is not the only entity to monitor reports of vaccination injury. The MHRA is the executive Agency of the Department of Health and Social Care in the UK that acts to protect and promote public health and patient safety, by ensuring that medicines and medical devices meet appropriate standards of safety, quality and efficacy.
The MHRA operates the Yellow Card scheme on behalf of the Commission on Human Medicines (CHM). The scheme collects and monitors information on suspected safety concerns or incidents involving vaccines, medicines, medical devices, and e-cigarettes. The scheme relies on voluntary reporting of suspected adverse incidents by healthcare professionals and members of the public (patients, users, or care givers). The purpose of the scheme is to provide an early warning that the safety of a product may require further investigation. Further information about the Yellow Card scheme, including its contribution to identifying safety issues can be found on the Yellow Card website.
MHRA provided an updated report published on the 29th April 2021. MHRA Yellow Card Reporting up to 21st April 2021. Cumulatively, 19 weeks for Pfizer (approx 18 million doses) and 15 weeks for AstraZeneca (approx 26.4 million doses) and 2 weeks for Moderna (approx 0.1 million doses)
Reactions - 149,082 (Pfizer) + 573,650 (AZ) + 660 (Moderna) + 1687 (Unknown) = 725,079
Reports - 52,130 (Pfizer) + 153,098 (AZ) + 228 (Moderna) + 541 (Unknown) = 205,997
Rather than post the list of the many side effects by company, the information was uploaded to a spreadsheet in order to create a clear graphic visualization of each manufacturers reported side effects.
While it's clear Moderna had the least reported side effect we must remember it also had the least amount time and lowest vaccinations compared with AstraZeneca and Pfizer. We have no way of knowing what long term side effects could appear from any vaccination in the months or even years to come.
* 33.3 million unique people received one or two doses
* 205,997 unique reports filed with Yellow Card
If MHRA reporting rate is 10% for serious adverse events and less for non-serious then this approximates 2 million people who should be filing a Yellow Card. This equates to one adverse event Yellow Card worthy injury or death for every 16 people injected….
With a virus that has a less than 1% transmissibility rate, is it worth trading the slight risk of catching a virus with a 99.9% population survival rate with taking a 1-in-16 chance of a life impacting/limiting or worse risk with unknown long term implications?
For a deeper dive: